期刊文献+

Nuclear medical molecular imaging of tumor angiogenesis: current status and future prospects 被引量:5

Nuclear medical molecular imaging of tumor angiogenesis: current status and future prospects
原文传递
导出
摘要 Objective To review the current status and progress on nuclear medical molecular imaging of angiogenesis. Data sources A literature search was performed in Medline and PubMed published in English up to May 31, 2012. The search terms were molecular imaging, nuclear medicine and angiogenesis. Study selection Articles studying molecular imaging of angiogenesis using radionuclide were selected and reviewed. Results Molecular imaging has been used for studying angiogenesis by targeting integrin aVI33, VEGF/VEGFR, and matrix metalloproteinases (MMPs) with radionuclide-labeled tracers. The technology has been shown to be able to assess the angiogenesis status and/or predict the efficacy of anti-angiogenic therapy. Future directions of the research on the molecular imaging of angiogenesis include development of new tracers with better tumor targeting efficacy, desirable pharmacokinetics, and easy translation to clinical applications. Conclusion Advances in molecular imaging of angiogenesis using radioculcide will make the technology a valuable tool for personalized anti-angiogenesis treatment. Objective To review the current status and progress on nuclear medical molecular imaging of angiogenesis. Data sources A literature search was performed in Medline and PubMed published in English up to May 31, 2012. The search terms were molecular imaging, nuclear medicine and angiogenesis. Study selection Articles studying molecular imaging of angiogenesis using radionuclide were selected and reviewed. Results Molecular imaging has been used for studying angiogenesis by targeting integrin aVI33, VEGF/VEGFR, and matrix metalloproteinases (MMPs) with radionuclide-labeled tracers. The technology has been shown to be able to assess the angiogenesis status and/or predict the efficacy of anti-angiogenic therapy. Future directions of the research on the molecular imaging of angiogenesis include development of new tracers with better tumor targeting efficacy, desirable pharmacokinetics, and easy translation to clinical applications. Conclusion Advances in molecular imaging of angiogenesis using radioculcide will make the technology a valuable tool for personalized anti-angiogenesis treatment.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第14期2741-2746,共6页 中华医学杂志(英文版)
关键词 molecular imaging nuclear medicine ANGIOGENESIS molecular imaging nuclear medicine angiogenesis
  • 相关文献

参考文献55

  • 1Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182-1186.
  • 2Tassinari D, Sartori S, Papi M, Drudi F, CasteUani C, Carloni F, et al. Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach. Oncology 2011; 80: 350-358.
  • 3Botrel TE, Clark O, Clark L, Paladini L, Faleiros E, Pegoretti B. Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): systematic review and recta-analysis. Lung Cancer 2011; 74: 89-97.
  • 4Sehgal R, Lembersky BC, Rajasenan KK, Crandall TL, Balaban EP, Pinkerton RA, et al. A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer. Clin Colorectal Cancer 2011; 10: 117-120.
  • 5Zee YK, O'Connor JP, Parker GJ, Jackson A, Clamp AR, TaylorMB, et al. Imaging angiogenesis of genitourinary tumors. Nat Rev Uro12010; 7: 69-82.
  • 6Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas. Curt Opin Neuro12008; 21: 728-735.
  • 7Fraioli F, Anzidei M, Zaccagna F, Mennini ML, Serra G, Gori B, et al. Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience. Radiology 2011; 259: 574- 582.
  • 8Chen Y J, Chu WC, Pu YS, Chueh SC, Shun CT, Tseng WY. Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer. J Magn Reson Imaging 2012; 36: 912-919.
  • 9Eichhom ME, Klotz LV, Luedemann S, Strieth S, Kleespies A, Preissler G, et al. Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation. Cancer Biol Ther 2010; 9: 794-802.
  • 10Aboagye EO, Gilbert F J, Fleming IN, Beer A J, Cunningham V J, Marsden PK, et al. Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials. Eur Radio12012; 22: 1465-1478.

同被引文献16

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部